Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season

THURSDAY, March 10, 2022 (HealthDay News) -- During the 2021-2022 season, influenza vaccination did not reduce the risk for outpatient medically attended illness with influenza A(H3N2) viruses that have predominated this season, according to research published in the March 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that most influenza viruses detected this season have been A(H3N2), Jessie R. Chung, M.P.H., from the CDC in Atlanta, and colleagues produced an interim report using data from 3,636 children and adults with acute respiratory infection during Oct. 4, 2021, to Feb. 12, 2022.
The researchers found that vaccine effectiveness against medically attended outpatient acute respiratory infection associated with influenza A(H3N2) virus was 16 percent overall, which was not statistically significant.
"Physicians should not wait for confirmatory influenza laboratory testing, and the decision to use antiviral medication should not be influenced by patient influenza vaccination status," the authors write. "Clinicians should be aware that influenza activity might continue or increase, and influenza should be considered as a possible diagnosis in all patients with acute respiratory infection."
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
Otra fuente de exposición al plomo en los niños: el humo de segunda mano
MIÉRCOLES, 23 de agosto de 2023 (HealthDay News) -- Una fuente de exposición al...
Impact of Climate Change on Neurologic Health Reviewed
THURSDAY, Nov. 17, 2022 (HealthDay News) -- The impact of climate change on...
Safer Opioid Supply Program Can Cut Adverse Clinical Outcomes, Health Costs
MONDAY, Sept. 19, 2022 (HealthDay News) -- For people with a diagnosis of opioid...
Disney Lifts Mask Mandates for the Fully Vaccinated
THURSDAY, Feb. 17, 2022 (HealthDay News) -- Masks will no longer be required for...